| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0889-8529(03)00069-0 |
| P698 | PubMed publication ID | 14711066 |
| P2093 | author name string | Virend K Somers | |
| Apoor S Gami | |||
| Sean M Caples | |||
| P2860 | cites work | Impact of sleep debt on metabolic and endocrine function | Q23731787 |
| The occurrence of sleep-disordered breathing among middle-aged adults | Q29547889 | ||
| Prospective study of the association between sleep-disordered breathing and hypertension | Q29620492 | ||
| Effect of very-low-calorie diets with weight loss on obstructive sleep apnea | Q30438026 | ||
| Changes in breathing and the pharynx after weight loss in obstructive sleep apnea | Q30463063 | ||
| Sleep-disordered breathing and glucose metabolism in hypertensive men: a population-based study | Q32155167 | ||
| Self assessment of daytime sleepiness: patient versus partner | Q33605188 | ||
| Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. | Q33855764 | ||
| Leptin, obesity, and respiratory function | Q33866555 | ||
| Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares | Q34054705 | ||
| The art and science of continuous positive airway pressure therapy in obstructive sleep apnea | Q34095606 | ||
| Utility of nocturnal home oximetry for case finding in patients with suspected sleep apnea hypopnea syndrome | Q34353370 | ||
| Prediction formulae for sleep-disordered breathing | Q34437079 | ||
| Effectiveness of CPAP treatment in daytime function in sleep apnea syndrome: a randomized controlled study with an optimized placebo | Q34517230 | ||
| Sleep apnoea and hypertension. | Q34539869 | ||
| Drug treatments for obstructive sleep apnoea | Q34699195 | ||
| The Sleep Apnea Syndromes | Q34726844 | ||
| The peripheral sympathetic nervous system in human obesity. | Q34741787 | ||
| The sympathetic nervous system and obesity: role in aetiology and treatment | Q34741897 | ||
| Sympathetic activity in obese subjects with and without obstructive sleep apnea | Q48788688 | ||
| Sleep apnoea and nocturnal angina. | Q48821990 | ||
| Occult sleep-disordered breathing in stable congestive heart failure | Q48822347 | ||
| Body fat distribution and sleep apnea severity in women | Q48824946 | ||
| Family studies in patients with the sleep apnea-hypopnea syndrome | Q48825036 | ||
| Mandibular advancement splint: an appliance to treat snoring and obstructive sleep apnea | Q48827362 | ||
| Impairment of cerebral perfusion during obstructive sleep apneas | Q48829441 | ||
| Insulin levels, blood pressure and sleep apnea. | Q48832253 | ||
| Plasma insulin and lipid levels in untreated obstructive sleep apnoea and snoring; their comparison with matched controls and response to treatment | Q48833064 | ||
| The predictive accuracy of home oximetry in patients with suspected obstructive sleep apnea. | Q48857961 | ||
| The association between hypertension and sleep apnea in obese patients | Q48862514 | ||
| Adiposity and cardiovascular risk factors in men with obstructive sleep apnea | Q48870363 | ||
| Bariatric surgery In morbidly obese sleep-apnea patients: short- and long-term follow-up | Q48888745 | ||
| Are History and Physical Examination a Good Screening Test for Sleep Apnea? | Q48900184 | ||
| Continuous positive airway pressure treatment results in weight less in obese and overweight patients with obstructive sleep apnea | Q47304378 | ||
| Increased C-reactive protein and increased plasma interleukin-6 may synergistically affect the progression of coronary atherosclerosis in obstructive sleep apnea syndrome | Q48636503 | ||
| Could elevated C-reactive protein in patients with obstructive sleep apnea be due to obesity per se? | Q48640259 | ||
| Elevated C-reactive protein in patients with obstructive sleep apnea | Q48660954 | ||
| Predictors of sleep-disordered breathing in community-dwelling adults: the Sleep Heart Health Study | Q48664229 | ||
| Obesity hypoventilation syndrome as a spectrum of respiratory disturbances during sleep | Q48682155 | ||
| Relation of measures of sleep-disordered breathing to neuropsychological functioning | Q48691694 | ||
| A randomized, controlled study of a mandibular advancement splint for obstructive sleep apnea | Q48693564 | ||
| Raised interleukin-6 levels in obese patients | Q48702097 | ||
| Overnight shift from obstructive to central apneas in patients with heart failure: role of PCO2 and circulatory delay | Q48704758 | ||
| Therapy with nCPAP: incomplete elimination of Sleep Related Breathing Disorder | Q48706258 | ||
| Effect of moderate alcohol upon obstructive sleep apnoea | Q48706279 | ||
| Fibrinogen levels and obstructive sleep apnea in ischemic stroke | Q48708426 | ||
| Platelet function in patients with obstructive sleep apnoea syndrome | Q48708646 | ||
| Serum leptin and vascular risk factors in obstructive sleep apnea | Q48713881 | ||
| Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy | Q48716348 | ||
| Respiratory disturbance index: an independent predictor of mortality in coronary artery disease | Q48717540 | ||
| Sleep-disordered breathing and myocardial ischemia in patients with coronary artery disease | Q48719721 | ||
| The efficacy of nasal continuous positive airway pressure in the treatment of obstructive sleep apnea syndrome is proven | Q48720134 | ||
| Prevalence of sleep apnea and electrocardiographic disturbances in morbidly obese patients | Q48721125 | ||
| Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia | Q48727889 | ||
| Sleep-disordered breathing among patients with first-ever stroke | Q48729312 | ||
| Nocturnal ischemic events in patients with obstructive sleep apnea syndrome and ischemic heart disease: effects of continuous positive air pressure treatment | Q48737933 | ||
| An independent association between obstructive sleep apnoea and coronary artery disease | Q48744179 | ||
| Effects of humidification on nasal symptoms and compliance in sleep apnea patients using continuous positive airway pressure | Q48747750 | ||
| Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy | Q48748953 | ||
| High prevalence and persistence of sleep apnoea in patients referred for acute left ventricular failure and medically treated over 2 months | Q48749160 | ||
| Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial | Q48759031 | ||
| Prevalence and severity of sleep disordered breathing in a group of morbidly obese patients | Q48760990 | ||
| Leptin prevents respiratory depression in obesity | Q48764953 | ||
| Sleep apnea in acute cerebrovascular diseases: final report on 128 patients | Q48766715 | ||
| The association between sleep apnea and the risk of traffic accidents. Cooperative Group Burgos-Santander | Q48769862 | ||
| Upper airway bypass surgery for obstructive sleep apnea syndrome | Q48783019 | ||
| Magnitude and time course of hemodynamic responses to Mueller maneuvers in patients with congestive heart failure | Q48787326 | ||
| Obstructive sleep apnoea | Q34754606 | ||
| Coagulation and fibrinolysis abnormalities in obesity | Q35037271 | ||
| Changes in comorbidities and improvements in quality of life after LAP-BAND placement | Q35044835 | ||
| Improving CPAP use by patients with the sleep apnoea/hypopnoea syndrome (SAHS). | Q35066292 | ||
| Night time versus daytime transient ischaemic attack and ischaemic stroke: a prospective study of 110 patients | Q35453086 | ||
| Pulmonary arterial hypertension in patients with sleep apnoea syndrome | Q35533481 | ||
| Waking genioglossal electromyogram in sleep apnea patients versus normal controls (a neuromuscular compensatory mechanism). | Q35602313 | ||
| Sympathetic neural mechanisms in obstructive sleep apnea. | Q35764596 | ||
| Model for investigating snorers with suspected sleep apnoea | Q36276701 | ||
| Mechanisms of Obstructive Sleep Apnea | Q36757751 | ||
| The efficacy of surgical modifications of the upper airway in adults with obstructive sleep apnea syndrome. | Q36825275 | ||
| Prevalent sleep problems in the aged | Q36866676 | ||
| A whole-genome scan for obstructive sleep apnea and obesity | Q37219579 | ||
| Sleep-Disordered Breathing in Community-Dwelling Elderly | Q37375065 | ||
| The relationship between obstructive sleep apnoea and body mass index | Q39456054 | ||
| A randomized crossover study of an oral appliance vs nasal-continuous positive airway pressure in the treatment of mild-moderate obstructive sleep apnea | Q39465864 | ||
| Obstructive sleep apnea and body weight | Q39605919 | ||
| Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea | Q39645233 | ||
| Predictive factors of long-term compliance with nasal continuous positive airway pressure treatment in sleep apnea syndrome | Q41043425 | ||
| Cardiac Output Response to Continuous Positive Airway Pressure in Congestive Heart Failure | Q41142563 | ||
| Motor control of the pharyngeal musculature and implications for the pathogenesis of obstructive sleep apnea | Q41403317 | ||
| Improvement in upper airway function after weight loss in patients with obstructive sleep apnea | Q41407467 | ||
| Genetics of human obesity: recent results from linkage studies | Q41581820 | ||
| Obstructive sleep apnoea in patients with dilated cardiomyopathy: effects of continuous positive airway pressure | Q42111963 | ||
| Pharyngeal size and resistance in obstructive sleep apnea | Q43654483 | ||
| Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). | Q43826703 | ||
| Obstructive sleep apnea is independently associated with insulin resistance. | Q43903080 | ||
| Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. | Q43903083 | ||
| Do patients with obstructive sleep apnea have thick necks? | Q43916210 | ||
| Body fat distribution, serum leptin, and cardiovascular risk factors in men with obstructive sleep apnea. | Q44133831 | ||
| Left ventricular systolic dysfunction in patients with obstructive sleep apnea syndrome | Q44178011 | ||
| Treatment of snoring and obstructive sleep apnea with a dental orthosis | Q44242704 | ||
| Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations | Q44554087 | ||
| Familial aggregation of body mass index: a population-based family study in eastern Finland | Q44660608 | ||
| Weight loss in mildly to moderately obese patients with obstructive sleep apnea | Q44711195 | ||
| Insulin resistance and sleep-disordered breathing in healthy humans | Q46141762 | ||
| A predictive morphometric model for the obstructive sleep apnea syndrome | Q46224131 | ||
| Contribution of craniofacial risk factors in increasing apneic activity among obese and nonobese habitual snorers | Q46424253 | ||
| Sleep disturbance and obesity: changes following surgically induced weight loss | Q47222002 | ||
| Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea | Q47234433 | ||
| Sleep apnea syndrome in the morbidly obese as an indication for weight reduction surgery | Q47244368 | ||
| The effect of weight loss on sleep-disordered breathing and oxygen desaturation in morbidly obese men. | Q47265018 | ||
| Long-term efficacy of dietary weight loss in sleep apnoea/hypopnoea syndrome | Q47274065 | ||
| The effect of a very low-calorie diet-induced weight loss on the severity of obstructive sleep apnoea and autonomic nervous function in obese patients with obstructive sleep apnoea syndrome | Q47282656 | ||
| Upper airway collapsibility in snorers and in patients with obstructive hypopnea and apnea | Q48904625 | ||
| Interaction of chemical and mechanical respiratory stimuli in the arousal response to hypoxia in sleeping dogs | Q48904688 | ||
| Daytime hypertension in obstructive sleep apnea. Prevalence and contributing risk factors | Q48907477 | ||
| Sleep apnoea patients have more automobile accidents | Q48974006 | ||
| Gastric surgery for respiratory insufficiency of obesity | Q49010051 | ||
| Severe obstructive sleep apnea--II: Associated psychopathology and psychosocial consequences | Q49052756 | ||
| Preliminary communication: intellectual deficit and sleep-related respiratory disturbance in the elderly. | Q49053044 | ||
| Obstructive sleep apnea in the morbidly obese. An indication for gastric bypass | Q49070414 | ||
| Sleep apnea syndrome treated by repair of deviated nasal septum | Q49106591 | ||
| Fluoroscopic and computed tomographic features of the pharyngeal airway in obstructive sleep apnea | Q49114782 | ||
| Effect of flurazepam on sleep-disordered breathing and nocturnal oxygen desaturation in asymptomatic subjects | Q49136650 | ||
| Right ventricular dysfunction in patients with obstructive sleep apnoea syndrome. | Q50932493 | ||
| Body fat and sympathetic nerve activity in healthy subjects. | Q54202550 | ||
| Leptin: a review of its peripheral actions and interactions | Q56169405 | ||
| Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians | Q57303378 | ||
| Snoring and risk of cardiovascular disease in women | Q57750780 | ||
| Elevated C-reactive protein levels in overweight and obese adults | Q57830181 | ||
| Leptin and the central neural mechanisms of obesity hypertension | Q58656715 | ||
| Neural mechanisms in human obesity-related hypertension | Q63479549 | ||
| Pathogenesis of upper airway occlusion during sleep | Q67355497 | ||
| Hypersomnia with periodic apneas in acquired micrognathia. A bird-like face syndrome | Q67850329 | ||
| Hemodynamics in sleep-induced apnea. Studies during wakefulness and sleep | Q67876016 | ||
| Indications and standards for cardiopulmonary sleep studies. American Thoracic Society. Medical Section of the American Lung Association | Q69483844 | ||
| Cognitive impairment in patients with obstructive sleep apnea and associated hypoxemia | Q69639354 | ||
| Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome | Q71147324 | ||
| Gastroplasty for respiratory insufficiency of obesity | Q71555957 | ||
| Upper airway and soft tissue anatomy in normal subjects and patients with sleep-disordered breathing. Significance of the lateral pharyngeal walls | Q71796369 | ||
| Sympathetic activation in obese normotensive subjects | Q72166672 | ||
| Sleep-related myocardial ischemia and sleep structure in patients with obstructive sleep apnea and coronary heart disease | Q73092761 | ||
| Visceral fat accumulation as an important risk factor for obstructive sleep apnoea syndrome in obese subjects | Q73092998 | ||
| Sleep-related breathing disorders, loud snoring and excessive daytime sleepiness in obese subjects | Q73896990 | ||
| Pulmonary hypertension in patients with obstructive sleep apnea syndrome | Q73912549 | ||
| Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects | Q73936894 | ||
| Relationship of a large weight loss to long-term weight change among young and middle-aged US women | Q74287061 | ||
| C-reactive protein is independently associated with total body fat, central fat, and insulin resistance in adult women | Q74845466 | ||
| Sympathetic neural activation in visceral obesity | Q78503922 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | obesity | Q12174 |
| P304 | page(s) | 869-894 | |
| P577 | publication date | 2003-12-01 | |
| P1433 | published in | Endocrinology and Metabolism Clinics of North America | Q15763298 |
| P1476 | title | Obesity and obstructive sleep apnea | |
| P478 | volume | 32 |
| Q46418681 | A 1H magnetic resonance spectroscopy study in patients with obstructive sleep apnea. |
| Q41832970 | Aorta macrophage inflammatory and epigenetic changes in a murine model of obstructive sleep apnea: Potential role of CD36. |
| Q40772123 | Association of Interleukin-10 gene promoter polymorphisms with obstructive sleep apnea |
| Q89998437 | Association of inflammatory genes in obstructive sleep apnea and non alcoholic fatty liver disease in Asian Indians residing in north India |
| Q48439260 | Association of sleep apnea severity and obesity with insulin resistance, C-reactive protein, and leptin levels in male patients with obstructive sleep apnea |
| Q58585726 | Associations between Attention-Deficit Hyperactivity Disorder (ADHD) Treatment and Patient Nutritional Status and Height |
| Q48034209 | Atrial Fibrillation Is Associated With Increased Mean Platelet Volume and Apnea Hypopnea Index in Patients With Obstructive Sleep Apnea |
| Q28284641 | Attention-deficit/hyperactivity disorder (ADHD) and obesity: a systematic review of the literature |
| Q33373168 | Autoadjusting-CPAP effect on serum leptin concentrations in obstructive sleep apnoea patients |
| Q48512646 | Body Mass Index (BMI) as a first-line screening criterion for detection of excessive daytime sleepiness among professional drivers |
| Q37496083 | Body Mass Index, Quality of Life, and Catheter Ablation in Patients with Atrial Fibrillation. |
| Q45229077 | Body mass index and headaches: findings from a national sample of US adults |
| Q38285363 | CPAP washout prior to reevaluation polysomnography: a sleep surgeon's perspective |
| Q37510446 | Circadian variability of fibrinolytic markers and endothelial function in patients with obstructive sleep apnea |
| Q48411115 | Clinical and societal consequences of obstructive sleep apnea and excessive daytime sleepiness |
| Q35995551 | Correlates of serum C-reactive protein (CRP)--no association with sleep duration or sleep disordered breathing. |
| Q53681657 | Correlation between metabolic syndrome and sleep apnea. |
| Q36897371 | Does CPAP lead to change in BMI? |
| Q31050648 | EFNS guideline on diagnosis and management of post-polio syndrome. Report of an EFNS task force |
| Q36327719 | Effect of bariatric surgery on cardiometabolic risk in elderly patients: A population-based study |
| Q47241468 | Effect of surgical weight loss on sleep architecture in adolescents with severe obesity |
| Q30410095 | Emotional modulation of pain and spinal nociception in persons with severe insomnia symptoms |
| Q34482619 | Excessive daytime sleepiness and body composition: a population-based study of adults |
| Q46832925 | Factors with influence on sleep apnea/hypopnea syndrome |
| Q47423404 | Glucose, insulin, and insulin resistance in normal-weight, overweight and obese children with obstructive sleep apnea |
| Q37737002 | Growth hormone/insulin-like growth factor-I axis in obstructive sleep apnea syndrome: an update. |
| Q48030586 | Healthy humans with a narrow upper airway maintain patency during quiet breathing by dilating the airway during inspiration. |
| Q38451844 | Inflammation, a link between obesity and atrial fibrillation. |
| Q48300324 | Is mandatory screening for obstructive sleep apnea with polysomnography in all severely obese patients indicated? |
| Q47965456 | Knowledge, opinions, and clinical experience of general practice dentists toward obstructive sleep apnea and oral appliances |
| Q35032091 | Lifestyle modifications and the resolution of obstructive sleep apnea syndrome: a case report |
| Q50242854 | Management of sleep apnea in the neurology patient: Five new things. |
| Q35092244 | Metabolic syndrome, insulin resistance, fibrinogen, homocysteine, leptin, and C-reactive protein in obese patients with obstructive sleep apnea syndrome |
| Q39428639 | Musculoskeletal deterioration in men accompanies increases in body fat. |
| Q33680948 | Neuroendocrine alterations in obese patients with sleep apnea syndrome |
| Q85239948 | Novel Electrocardiographic Parameters of Altered Repolarization in Uncomplicated Overweight and Obesity |
| Q47139872 | Obesity and obstructive sleep apnea risk among Nigerians |
| Q48471005 | Obesity and the risk of appropriate defibrillator therapies in MADIT II trial |
| Q44911385 | Obesity as a risk factor for premenstrual syndrome |
| Q36382360 | Obesity, diabetes and atrial fibrillation; epidemiology, mechanisms and interventions. |
| Q60624622 | Obstructive Sleep Apnea and Obesity: Implications for Public Health |
| Q38873744 | Obstructive sleep apnea and postoperative complications among patients undergoing gynecologic oncology surgery. |
| Q26778430 | Obstructive sleep apnea as a risk factor for type 2 diabetes mellitus |
| Q26829006 | Obstructive sleep apnea in North American commercial drivers |
| Q43681660 | Obstructive sleep apnea in extremely overweight adolescents undergoing bariatric surgery |
| Q47651779 | Obstructive sleep apnea syndrome among obese individuals: A cross-sectional study |
| Q43892293 | Obstructive sleep apnea syndrome and its association with vitamin D deficiency |
| Q37807683 | Obstructive sleep apnea: diagnosis, risk factors, and pathophysiology |
| Q48459791 | Obstructive sleep apnoea, glucose tolerance and liver steatosis in obese women |
| Q34952353 | Overlap syndrome between chronic obstructive pulmonary disease and obstructive sleep apnoea in a Southeast Asian teaching hospital |
| Q36635045 | Pathogenesis of cognitive dysfunction in patients with obstructive sleep apnea: a hypothesis with emphasis on the nucleus tractus solitarius |
| Q64086922 | Perception and Management of Obesity Among Pakistani Doctors |
| Q40543848 | Phenotypes of comorbidity in OSAS patients: combining categorical principal component analysis with cluster analysis |
| Q36045806 | Polysomnography in patients with obstructive sleep apnea: an evidence-based analysis |
| Q41717628 | Predictive factors for difficult mask ventilation in the obese surgical population |
| Q43586123 | Prevalence of self-reported clinically diagnosed sleep apnea according to obesity status in men and women: National Health and Nutrition Examination Survey, 2005-2006. |
| Q37429694 | Recognition and management of excessive sleepiness in the primary care setting |
| Q41586659 | Relationship between obstructive sleep apnea and nonalcoholic fatty liver disease in nonobese adults |
| Q45349700 | Relationship between obstructive sleep apnea syndrome and thyroid diseases |
| Q37605741 | Risk assessment of obstructive sleep apnea syndrome in pediatric patients with vitamin D deficiency: A questionnaire-based study |
| Q42113030 | Sinonasal Characteristics in Patients with Obstructive Sleep Apnea Compared to Healthy Controls. |
| Q33717848 | Sleep and diabetes |
| Q37158014 | Sleep apnea: a proinflammatory disorder that coaggregates with obesity |
| Q37903216 | Sleep apnea: a risk factor for obese burned children during the rehabilitative phase of injury |
| Q33790379 | Sleep duration and obesity in a population-based study |
| Q47640346 | Sleep in overweight adolescents: shorter sleep, poorer sleep quality, sleepiness, and sleep-disordered breathing |
| Q92637811 | Strobilanthes crispus Extract Reduces Respiratory Exchange Ratio in Obese Mice Fed High Fat and Low Fat Diets |
| Q46896389 | Symptoms of obstructive sleep apnea in patients with nonalcoholic fatty liver disease |
| Q58799135 | The Bidirectional Relationship Between Obstructive Sleep Apnea and Metabolic Disease |
| Q47441053 | The importance of follow-up and distance from centre in weight loss after laparoscopic adjustable gastric banding |
| Q92532921 | The supraglottic airway device as first line of management in anticipated difficult mask ventilation in the morbidly obese |
| Q36304282 | Therapy Insight: interactions between atrial fibrillation and obstructive sleep apnea |
| Q35995476 | Two year reduction in sleep apnea symptoms and associated diabetes incidence after weight loss in severe obesity. |
| Q53401955 | Vibration signals of snoring as a simple severity predictor for obstructive sleep apnea. |
Search more.